PA-23-044 - Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

On This Page: 4

Active NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)
Notice of Special Interest (NOSI): Impacts of Psychedelic and Dissociative Drug Policy Changes on Public Health Outcomes NOT-DA-24-010 NIDA Jun 13, 2023 Sep 8, 2026 R03, 333, R01, R15, R21

Expired NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)
Notice of Special Interest (NOSI): Competitive Revision Awards to National Institute on Minority Health and Health Disparities (NIMHD) Multiple Chronic Disease Centers for Emerging Therapeutic Interventions NOT-MD-23-009 NIMHD May 26, 2023 Jul 22, 2023 333
Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions to Add or Expand Research and Administrative Supplements on Cutting Edge Pain Research in Rheumatic, Skin, and Musculoskeletal Disease. NOT-AR-23-015 NIAMS Mar 3, 2023 Jun 7, 2023 333
Notice of Special Interest: Administrative Supplements and Urgent Competitive Revisions on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA NOT-AA-22-002 NIAAA Dec 2, 2021 May 8, 2024 333
For technical issues E-mail OER Webmaster